EGRX
Eagle Pharmaceuticals, Inc.
EGRX
EGRX
Delisted
EGRX was delisted on the 2nd of October, 2024.
182 hedge funds and large institutions have $567M invested in Eagle Pharmaceuticals, Inc. in 2018 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 71 increasing their positions, 53 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
182
Holders Change
-7
Holders Change %
-3.7%
% of All Funds
4.06%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
27
Increased
71
Reduced
53
Closed
34
Calls
$3.18M
Puts
$6.12M
Net Calls
-$2.94M
Net Calls Change
-$5.36M
Top Buyers
| 1 |
PWAM
Park West Asset Management
San Francisco,
California
|
+$12.4M |
| 2 |
Millennium Management
New York
|
+$11M |
| 3 |
WG
Winton Group
London,
United Kingdom
|
+$9.55M |
| 4 |
D.E. Shaw & Co
New York
|
+$6.31M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$4.49M |
